Group purchasing organization Vizient reported a 610 percent boost in demand from June 16-19, the period just after preliminary study results suggested dexamethasone — an inexpensive steroid often used to treat asthma, arthritis and some cancers — could improve mortality rates among the sickest COVID-19 patients.
The rate at which drugmakers could fill dexamethasone orders and send them to hospitals dropped from 97 to 54 percent by June 19, according to Vizient.
More articles on pharmacy:
Ramping up US drug production: 3 obstacles to consider
APhA launches task force, #PharmacistsFightingRacism campaign
Sanofi expedites its vaccine timeline, strikes $2.3B deal with Translate Bio
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
